Susan Hall, Ph.D. has been appointed executive vice president, chief scientific officer and global head of R&D and quality, at Endo International plc. Dr. Hall will be based in Dublin, Ireland at the company's new global corporate headquarters.
Prior to joining the company, Dr. Hall served as senior vice president and global head of R&D at Valeant Pharmaceuticals International, where she led the company's product pipeline and life cycle management activities with responsibility for quality compliance. Dr. Hall has also held various leadership roles in R&D at GlaxoSmithKline including clinical pharmacology, project management, medical affairs, and regulatory affairs.
"We are thrilled that Sue has joined the Endo team as the progression of Endo to a leading specialty healthcare company continues," said Rajiv De Silva, president and chief executive officer of Endo. "Sue brings more than 30 years of extensive multi-disciplinary and international expertise in drug development and life cycle management across a broad range of therapeutic areas along with extensive experience in quality. R&D will continue to be a key part of Endo's future organic growth plans and Sue's experience and background make her an excellent fit for the role."